US EditionTruly Novel RA Drug Passes Mid-Stage Test
Summary by MedPage Today
1 Articles
1 Articles
All
Left
Center
1
Right
Truly Novel RA Drug Passes Mid-Stage Test
(MedPage Today) -- Combining the Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) with an investigational oral drug targeting a different type of kinase enzyme was more effective against rheumatoid arthritis (RA) than tofacitinib alone in a phase...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage